Blue

Tech transfer experts from the University of Pennsylvania and Albert Einstein College of Medicine breakdown each pathway to commercialization. 

License, Spin Out, or Publish? How to Make the Translational Call

Milestone-based financing can be an effective way for investors to manage risk and for founders to complete successful clinical trials and gain regulatory approval. Here's what biotech entrepreneurs need to know before seeking this type of funding. 

The Pros and Cons of Milestone-Based Financing for Biotech Startups

Whether pitching to angels, applying to accelerators, or negotiating venture capital, knowing the right funding terms can make or break your credibility as a healthcare founder. This guide breaks down the must-know concepts to help you speak the language of investors and secure the capital you need to grow.

The Language of Startup Funding: 35 Terms Every Founder Should Know 

Experts advise focusing on three main factors that can help founders refine their message, highlight market fit, and ultimately secure funding. 

Tips for Building a Healthcare Pitch Deck That Wins Over Investors

More than one-third of all new life sciences lab construction in the U.S. is taking place outside the traditional power centers, ushering a new era of geographic growth.

Biotech's New Hubs Are Booming—Here Are the Places Investors and Manufacturers Are Betting On Image

Biotech's New Hubs Are Booming—Here Are the Places Investors and Manufacturers Are Betting On

Collaborations fuel biotech and healthcare innovation, but unclear agreements can lead to costly IP disputes. Patent litigator Anthony J. Fitzpatrick of Duane Morris LLP explains how entrepreneurs can safeguard ownership, avoid accidental disclosures, and structure deals that protect long-term value.

How to Protect Your Healthcare IP When Collaborating

From misaligned investor expectations to trial design pitfalls, healthcare entrepreneurs face obstacles on their road to growth. Experts from Rev1 Ventures and Vittoria Biotherapeutics share how to anticipate these challenges, and turn them into points of progress.

8 Early-Stage Hurdles Your Healthcare Startup Could Face—and How To Overcome Them Image

8 Early-Stage Hurdles Your Healthcare Startup Could Face—and How To Overcome Them

Five finalists from around the globe are pitching their transformative healthcare technologies, which span personalized cancer therapies, postpartum depression diagnostics, AI-driven cell and gene therapy manufacturing, hospital workflow systems, and next-generation gene editing.

Meet the Five Finalists in the King Faisal & Davos of Healthcare Innovation Challenge 

Intellectual property (IP) is often a startup’s most valuable asset. Patent litigator Anthony J. Fitzpatrick of Duane Morris LLP shares what healthcare entrepreneurs need to know about patents, trade secrets, and copyrights, plus common costly mistakes to avoid.

How Healthcare Entrepreneurs Can Protect Their Innovations: Patents

With more than $2.5 billion raised since 2019, BioLabs@NYULangone is giving healthcare entrepreneurs the tools, capital access, and collaborative ecosystem needed to accelerate innovation in life sciences.

How BioLabs Builds a Launchpad for Life Science Startups image

How BioLabs@NYULangone Builds a Launchpad for Life Science Startups

The BioVenture eLab, part of Weill Cornell Medicine Enterprise Innovation, equips innovators with business expertise, funding pathways, and investor connections to accelerate the translation of ideas to the marketplace.

Turning Research into Healthcare Startups: Weill Cornell Medicine’s BioVenture eLab

Richard Magid, PhD, Vice President of Technology Transfer at Colorado State University explains how university faculty and students can navigate IP, licensing, and partnerships to commercialize healthcare discoveries.

From Lab to Market: How Tech Transfer Turns Research into Real-World Impact image

From Lab to Market: How Tech Transfer Turns Research into Real-World Impact

More PhDs are trading academia for entrepreneurship. Founders from Aggregate Biosciences, Celmatix Therapeutics, Daré Bioscience, Gameto, GenKardia and Metallomix share how mentorship, business acumen, and the right support systems can turn discoveries into thriving startups.

From Lab Bench to Startup: How Scientists Can Make the Leap 

Accelerators and incubators both offer mentorship, resources, and investor access, but their structures, timelines, and risks vary. Here’s what healthcare entrepreneurs need to know to choose what’s best for their startup.

Accelerator vs. Incubator: Which is Right for Your Healthcare Startup?

Core facilities equip healthcare innovators with shared access to advanced technologies, expert support and collaborative insights to accelerate discovery while reducing costs.

How Core Facilities Accelerate Healthcare Innovation

At a time when federal funding is shrinking, healthcare startups are finding critical support from mission-driven venture philanthropies like the ADDF and LLS willing to back early-stage, high-risk science.

Is Venture Philanthropy Right for Your Startup? Here’s How to Tell

Leaders from NYCEDC, Ally Bridge Group and Hunter College share how mentorship drives innovation, sharpens leadership skills, and expands professional networks.

Mentoring Pays Off: How Guiding Others Can Boost Your Own Career

Strong mentorships can accelerate your entrepreneurial journey. Experts from NYCEDC, Ally Bridge Group, and Hunter College share how to communicate, build trust and get the most out of a mentor relationship.

6 Tips to Maximize Your Mentor Relationship

The International Center for Professional Development connects underrepresented scholars and African entrepreneurs with healthcare industry mentors, training and opportunities.

How Mentoring Programs Fuel Pipeline of Healthcare Entrepreneurs 

Mentors are trusted allies whose valuable experience-based wisdom can open doors for healthcare entrepreneurs navigating from startup to longterm success.

5 Smart Ways to Find a Mentor Who Moves Your Healthcare Career Forward

Five healthcare entrepreneurs share pivotal mentorship advice that helped them navigate career shifts and overcome scientific setbacks.

What My Mentor Taught Me: Healthcare Entrepreneurs Share Lessons Learned

Lux Capital's initiative offers money, mentorship and migration pathways to keep scientific discoveries alive amidst rising international competition for America's innovators.

Lux Capital Launches $100M ‘Helpline’ for U.S. Scientists

Sunbird Bio’s CEO shares how focus, timing, and smart scaling can turn biotech volatility into long-term value.

4 Steps to Building a Biotech Company That Lasts image

4 Steps to Building a Biotech Company That Lasts

Academic institutions and industry leaders are forging new pathways to commercialize cutting-edge research.

Universities and Industry Join Forces to Advance Innovation image

Universities and Industry Join Forces to Advance Innovation

Description: Leading U.S. universities are launching Faculty Innovation Ambassador Programs to train and support entrepreneurial faculty, accelerating the commercialization of academic discoveries and bridging the gap between research and industry.

Universities Empower Faculty to Drive Innovation to Market image

Universities Empower Faculty to Drive Innovation to Market

With the help of a 2023 XSeed Award, Rohini Kavlakuntla, MSc, and her two graduate school buddies are advancing the work of their startup Helex to make genetic medicine accessible and affordable for those with debilitating kidney diseases.

xseed-past-winner-rohini_kalvakuntla

From Friends to Founders: On a Mission to Combat Kidney Disease

Nigerian-born Chidiebere Awah, MD, PhD, CEO of UTR Therapeutics Inc., has created a technology with potential to not only take on aggressive cancers, but also Alzheimer’s disease, metabolic diseases and more.

Chidiebere Uzodinma Awah, MD, PhD, CEO of UTR Therapeutics Inc.

How Funding and Mentorship Forged a New Path to Fight Cancer

Understanding how life sciences entrepreneurs can best use patents and copyrights to safeguard IP as an asset offers protection against others copying the discovery and can help set up a smoother path to market.
 

thumbnail-intellectual-property-article

The Ins and Outs of Intellectual Property in Life Sciences

Jahanara Ali, PhD, of NomoCan Pharmaceuticals, is developing a first-in-class monoclonal antibody to treat patients with the blood cancer acute myeloid leukemia (AML), but it may have applications for solid tumor cancers.

thumbnail-xseed-2024-jahanara-ali

Spotlight on XSeed Award Finalist: Jahanara Ali, PhD, Chief Business Officer, NomoCan Pharmaceuticals

Paraskevi Giannakakou, PhD, is developing a first-in-class small molecule that may defeat the resistance many patients with advanced prostate cancer develop to standard-of-care anticancer drugs.

thumbnail-xseed-2024-evi-giannakakou

Spotlight on XSeed Award Finalist: Paraskevi Giannakakou, PhD, Co-Founder, ARMA BIO

Nader Halim, PhD, MBA, offers insights to entrepreneurial academics, drawing on his time at Genentech, Pfizer and as CEO of Innervace, a biotech working to restore the brain circuits in people with Parkinson’s disease. 


From Academia to Startup CEO: Four Tips on Taking the Leap -- 324356487

From Academia to Startup CEO: Four Tips on Taking the Leap 

Biotech startups are notoriously high-risk ventures, and most of them fail. What sets apart the ones that succeed?

Five Strategies for Biotech Startup Success

Tony Boccanfuso, PhD, President and CEO of the University-Industry Demonstration Project, discusses the value of fruitful partnerships between academic institutions and companies.

8 Early-Stage Hurdles Your Healthcare Startup Could Face—and How To Overcome Them

Cure by Deerfield Launches Middle East Health Accelerator in Qatar

Your Home in NYC

November 11 -13 , 2025

Cure Presents: The X Factor Healthcare Innovation Summit

Accelerating Advances in Health

Translational Research

Insights

Recommended Topics

Join our community